Clinical Trial Update: AVERT Plus Post-Market Registry

View source ↗

Summary

The AVERT Plus Post-Market Registry sponsored by Osprey Medical has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• AVERT Plus

Snippet

Sponsor: Osprey Medical, Inc | Conditions: Coronary Artery Disease | Status: TERMINATED